Clinical Trial Update: A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer [NA]

View source ↗

Summary

This trial update reports completion of a prospective cohort study evaluating the Oncotype DX Recurrence Score test in early-stage breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Oncotype DX Recurrence Score test (Oncotype DX Recurrence Score assay)

Snippet

Sponsor: Ontario Clinical Oncology Group (OCOG) | Conditions: Breast Cancer | NA | Status: COMPLETED